Many of the pharma industry’s biggest companies have over the last week added to their condemnation of Russia’s invasion of Ukraine by declaring a halt to investment in the country and suspension of clinical trials.
Pharma Companies Are Suspending Trials In Russia - But For Practical More Than Ethical Reasons
Sanctions Block Payments For Studies
While pharma is keen to condemn Russia’s aggression, suspension of trials is for practical reasons, and not a punishment of the country’s patients.
